Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1667]

5 years of tamoxifen improves 15-year survival by about a third in women with most common type of breast cancer

5 years of tamoxifen improves 15-year survival by about a third in women with most common type of breast cancer

Mechanical bowel preparation does not improve outcomes following surgery for colon cancer

Mechanical bowel preparation does not improve outcomes following surgery for colon cancer

Pancreatic Cancer: Challenges and Hopes

Pancreatic Cancer: Challenges and Hopes

Denosumab approved in Europe

Denosumab approved in Europe

Study predicts improved survival in primary mediastinal nonseminomatous germ cell tumours

Study predicts improved survival in primary mediastinal nonseminomatous germ cell tumours

Trastuzumab and chemotherapy improved survival in HER2-positive breast and brain cancer patients

Trastuzumab and chemotherapy improved survival in HER2-positive breast and brain cancer patients

One-to-one therapy to manage urinary incontinence in men following prostate surgery no more effective than standard care

One-to-one therapy to manage urinary incontinence in men following prostate surgery no more effective than...

Many advanced breast cancer patients do not receive recommended treatment

Many advanced breast cancer patients do not receive recommended treatment

Collagen scaffolding drives tumour growth

Collagen scaffolding drives tumour growth

Poorer women less likely to survive breast cancer

Poorer women less likely to survive breast cancer

More from ecancer